Tonix Pharmaceuticals Holding Corp (TNXP)
0.6116
+0.04
(+7.30%)
USD |
NASDAQ |
Dec 20, 16:00
0.5106
-0.10
(-16.51%)
After-Hours: 20:00
Tonix Pharmaceuticals Shareholders Equity (Quarterly): 74.21M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 39.80B |
| Emergent BioSolutions Inc | 508.40M |
| Amicus Therapeutics Inc | 178.82M |
| Chimerix Inc | 135.78M |
| Geovax Labs Inc | 8.504M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.99M |
| Total Liabilities (Quarterly) | 20.78M |
| Debt to Equity Ratio | 0.1077 |
| Current Ratio | 3.329 |
| Net Debt Paydown Yield | -1.21% |